PLUR Logo

Pluri Inc. (PLUR) 

NASDAQ
Market Cap
$25.6M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
831 of 958
Rank in Industry
463 of 549

Largest Insider Buys in Sector

PLUR Stock Price History Chart

PLUR Stock Performance

About Pluri Inc.

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of …

Insider Activity of Pluri Inc.

Over the last 12 months, insiders at Pluri Inc. have bought $0 and sold $0 worth of Pluri Inc. stock.

On average, over the past 5 years, insiders at Pluri Inc. have bought $6.65M and sold $1.89M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 80,616 shares for transaction amount of $145,109 was made by Aberman Zami (director) on 2022‑02‑10.

List of Insider Buy and Sell Transactions, Pluri Inc.

2022-12-20Saledirector
2,000
0.0062%
$0.97$1,940-19.19%
2022-02-10Purchasedirector
80,616
0.4663%
$1.80$145,109-36.99%
2021-05-28Sale10 percent owner
115,007
1.3749%
$3.72$427,826-32.34%
2021-05-27Sale10 percent owner
95,885
1.137%
$3.69$353,816-31.97%
2021-05-26Sale10 percent owner
144,678
1.7117%
$3.68$532,635-32.25%
2021-05-25Sale10 percent owner
261,238
3.2238%
$3.84$1M-31.32%
2021-05-24Sale10 percent owner
79,300
0.976%
$3.83$303,719-33.95%
2021-05-21Sale10 percent owner
69,838
0.8932%
$3.98$277,955-35.17%
2021-05-03Sale10 percent owner
23,721
0.3263%
$4.28$101,526-37.50%
2021-04-30Sale10 percent owner
166,004
2.486%
$4.66$773,579-37.03%
2020-11-30Purchase10 percent owner
20,000
0.6234%
$9.70$194,000-60.93%
2020-10-30Purchase10 percent owner
50,000
1.5281%
$9.51$475,500-54.05%
2020-10-29Purchase10 percent owner
20,000
0.5913%
$9.20$184,000-53.92%
2020-09-30Purchase10 percent owner
139,006
4.619%
$10.34$1.44M-54.65%
2020-09-29Purchase10 percent owner
60,123
1.8858%
$9.76$586,800-52.72%
2020-09-28Purchase10 percent owner
13,189
0.4022%
$9.49$125,164-49.42%
2020-09-24Purchase10 percent owner
34,800
1.0087%
$9.02$313,896-45.34%
2020-09-23Purchase10 percent owner
10,734
0.3117%
$9.04$96,983-46.14%
2020-07-31Purchase10 percent owner
14,536
0.4405%
$9.43$137,074-28.67%
2020-07-30Purchase10 percent owner
51,235
1.5131%
$9.19$470,850-23.58%

Insider Historical Profitability

<0.0001%
YANAY YAKYCo-CEO & President
4253045
76.5121%
$4.61117+5.96%
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
3121918
56.1631%
$4.61288<0.0001%
MERETSKI SHAI10 percent owner
2400000
43.1759%
$4.6110
Aberman Zamidirector
1491973
26.8405%
$4.61138+1.24%
BRAUN ISAACdirector
636208
11.4453%
$4.6110<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.